tiprankstipranks
Trending News
More News >
MedCap AB (DE:61MA)
FRANKFURT:61MA
Germany Market
Advertisement

MedCap AB (61MA) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
4Neutral
12Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
MedCap AB’s (61MA) Moving Averages Convergence Divergence (MACD) indicator is -0.68, suggesting MedCap AB is a Sell.
MedCap AB’s (61MA) 20-Day exponential moving average is 49.64, while MedCap AB’s (61MA) share price is €48.35, making it a Sell.
MedCap AB’s (61MA) 50-Day exponential moving average is 50.78, while MedCap AB’s (61MA) share price is €48.35, making it a Sell.

MedCap AB (61MA) Pivot Points

Dec 10, 2025, 08:42 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
48.85
48.85
48.85
48.85
48.85
48.85
48.85
Fibonacci
48.85
48.85
48.85
48.85
48.85
48.85
48.85
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MedCap AB (61MA) Moving Averages

Dec 10, 2025, 08:42 AM
Period
Simple
Exponential
MA5
49.13Sell
48.92Sell
MA10
49.41Sell
49.18Sell
MA20
49.17Sell
49.64Sell
MA50
51.08Sell
50.78Sell
MA100
53.51Sell
50.45Sell
MA200
45.55Buy
46.38Buy
MedCap AB’s (61MA) 10-Day exponential moving average is 49.18, while MedCap AB’s (61MA) share price is €48.35, making it a Sell.
MedCap AB’s (61MA) 100-Day exponential moving average is 50.45, while MedCap AB’s (61MA) share price is €48.35, making it a Sell.
MedCap AB’s (61MA) stock price is €48.35 and MedCap AB’s (61MA) 50-day simple moving average is 51.08, creating a Sell signal.
MedCap AB’s (61MA) stock price is €48.35 and MedCap AB’s (61MA) 100-day simple moving average is 53.51, creating a Sell signal.
MedCap AB’s (61MA) stock price is €48.35 and MedCap AB’s (61MA) 200-day simple moving average is 45.55, creating a Buy signal.

MedCap AB (61MA) Technical Indicators

Dec 10, 2025, 08:42 AM
Name
Value
Implied Action
RSI (14)
40.08
Neutral
STOCH (9,6)
5.83
Buy
STOCHRSI (14)
22.67
Neutral
MACD (12,26)
-0.68
Sell
ADX (14)
16.45
Buy
Williams %R
-86.00
Buy
CCI (14)
-88.80
Neutral
ATR (14)
0.63
-
Ultimate Oscillator
38.69
Neutral
ROC
0.52
Buy
MedCap AB’s (61MA) Relative Strength Index (RSI) is 40.08, creating a Neutral signal.
MedCap AB’s (61MA) Trend Strength Indicator (ADX) is 16.45, creating a Buy signal.
MedCap AB’s (61MA) Commodity Channel Index (CCI) is -88.80, creating a Neutral signal.
MedCap AB’s (61MA) Price Rate of Change (ROC) is 0.52, creating a Buy signal.

FAQ

Is 61MA a Buy, Hold, or Sell?
Based on 61MA’s technical indicators, 61MA is a Sell.
    What is 61MA’s RSI (14)?
    61MA’s RSI (14) is 40.08, which suggests 61MA is a Neutral.
      What is 61MA’s MACD?
      61MA’s MACD is -0.68, which suggests 61MA is a Sell.
        What is 61MA’s 5-day moving average?
        61MA’s 5-day moving average is 49.13, which suggests 61MA is a Sell.
          What is 61MA’s 20-day moving average?
          61MA 20-day moving average is 49.17, which suggests 61MA is a Sell.
            What is 61MA’s 50-day moving average?
            61MA’s 50-day moving average is 51.08, which suggests 61MA is a Sell.
              What is 61MA’s 200-day moving average?
              61MA’s 200-day moving average is 45.55, which suggests 61MA is a Buy.
                What is 61MA’s Williams % R (14)?
                61MA’s Williams % R (14) is -86.00, which suggests 61MA is a Buy.
                  What is 61MA’s CCI (14)?
                  61MA’s CCI (14) is -88.80, which suggests 61MA is a Neutral.
                    What is the share price of MedCap AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis